The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

Bristol-Myers Squibb Co

NYSE: BMY
Last

(U.S.) $60.79

Today's change0.00 0.00%
Updated December 18 4:04 PM EST. Delayed by at least 15 minutes.
 

Bristol-Myers Squibb Co

NYSE: BMY
Last

(U.S.) $60.79

Today's change0.00 0.00%
Updated December 18 4:04 PM EST. Delayed by at least 15 minutes.

Bristol-Myers Squibb Co closed at (U.S.)$60.79.

Over the last five days, shares have gained 1.86% and 14.37% year to date. Shares have performed in-line with the S&P 500 during the last year.

Key company metrics

  • Open(U.S.) $0.00
  • Previous close(U.S.) $60.79
  • High--
  • Low--
  • Bid / Ask(U.S.) $58.03 / (U.S.) $61.46
  • YTD % change+14.37%
  • Volume0
  • Average volume (10-day)6,789,652
  • Average volume (1-month)5,865,278
  • Average volume (3-month)6,829,392
  • 52-week range(U.S.) $46.30 to (U.S.) $61.20
  • Beta0.34
  • Trailing P/E37.34×
  • P/E 1 year forward33.76×
  • Forward PEG2.81×
  • Indicated annual dividend(U.S.) $1.48
  • Dividend yield2.43%
  • Trailing EPS(U.S.) $1.63
Updated December 18 4:04 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+17.04%

Based on its net profit margin of 17.04%, Bristol-Myers Squibb Co is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.00%Sector:HealthcareIndustry:Pharmaceuticals - Diversified
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2014Q2/2014Q1/2014Q4/2013
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014Dec 31, 201312/31/2013
Revenue3,9213,8893,8114,441
Total other revenue--------
Total revenue3,9213,8893,8114,441
Gross profit2,9502,9372,8883,168
Total cost of revenue9719529231,273
Total operating expense3,2103,4493,0903,586
Selling / general / administrative1,2001,1381,1201,322
Research & development918958898957
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)19253820766
Other operating expenses, total-71-137-58-32
Operating income711440721855
Interest income (expense), net non-operating-50-46-54-53
Gain (loss) on sale of assets315-72591
Other--------
Income before tax1,008448985869
Income after tax732334936735
Income tax, total27611449134
Net income721333937726
Total adjustments to net income------0
Net income before extra. items721333937726
Minority interest-11-11-9
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items721333937726
Inc. avail. to common incl. extra. items721333937726
Diluted net income721333937726
Dilution adjustment--------
Diluted weighted average shares1,6701,6691,6661,671
Diluted EPS excluding extraordinary itemsvalue per share0.430.200.560.43
Dividends per sharevalue per share0.360.360.360.35
Diluted normalized EPSvalue per share0.350.580.600.36